首页> 外文会议>Society for Biomaterials annual meeting and exposition >SynthoPlate™: An Intravenous Synthetic Hemostat for Pre-hospital Treatment of Traumatic Hemorrhage
【24h】

SynthoPlate™: An Intravenous Synthetic Hemostat for Pre-hospital Treatment of Traumatic Hemorrhage

机译:SynthoPlate™:静脉合成止血药,用于院前治疗创伤性出血

获取原文

摘要

SynthoPlate™ is safe upon systemic administration and can significantly improve hemostasis and survival in small and large animal models of traumatic hemorrhage. Additionally, SynthoPlate™ can be sterilized and effectively stored for up to 6 months. Overall, our data suggest the promise of this technology for pre-hospital management of traumatic hemorrhage. Future studies are aimed at addressing technical hurdles associated with clinical translation including large-scale manufacturing, FDA regulation and clinical trials.
机译:SynthoPlate™在全身给药时是安全的,并且可以在创伤性出血的大小动物模型中显着改善止血效果和存活率。此外,SynthoPlate™可以消毒并有效保存长达6个月。总体而言,我们的数据表明该技术有望在创伤前的院前处理中得到应用。未来的研究旨在解决与临床翻译相关的技术障碍,包括大规模生产,FDA法规和临床试验。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号